SomaLogic

OverviewSuggest Edit

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic, Inc. was founded in 1999 and is headquartered in Boulder, Colorado.

TypePrivate
Founded2000
HQBoulder, US
Websitesomalogic.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Sep 2019)206

Key People/Management at SomaLogic

Larry Gold

Larry Gold

Chairman and CEO
Scott Kothlow

Scott Kothlow

CFO
Stephen A. Williams

Stephen A. Williams

Chief Medical Officer
Nebojsa Janjic

Nebojsa Janjic

Chief Science Officer
Show more

SomaLogic Office Locations

SomaLogic has an office in Boulder
Boulder, US (HQ)
2945 Wilderness Pl
Show all (1)

SomaLogic Financials and Metrics

Summary Metrics

Founding Date

2000

SomaLogic total Funding

$541.5 m

SomaLogic latest funding size

$200 m

Time since last funding

2 years ago

SomaLogic investors

SomaLogic's latest funding round in January 2018 was reported to be $200 m. In total, SomaLogic has raised $541.5 m
Show all financial metrics

SomaLogic Online and Social Media Presence

Embed Graph

SomaLogic News and Updates

Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays

Use of Agilent's custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development.read more

SomaLogic to Present at 37th Annual J. P. Morgan Healthcare Conference

BOULDER, Colo., Jan. 2, 2019 /PRNewswire/ -- SomaLogic, Inc., announced today that its new Chief Executive Officer, Roy Smythe, M.D., will present the company's current status and strategic direction at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Dr....

Roy Smythe, M.D., selected as next CEO of SomaLogic

BOULDER, Colo., Nov. 14, 2018 /PRNewswire/ -- The SomaLogic Board of Directors announced today that they have selected Roy Smythe, M.D. as the next Chief Executive Officer of SomaLogic. "As SomaLogic draws closer to our goal of being a global leader in health information, we must continue ...

Aptamers Market to Surge Past US$ 10,407 Million by 2025 due to Widened Application Area

Global Aptamers Market, By Type (Nucleic Acid Aptamers, Peptide Aptamers), Application (Diagnostics, Therapeutics, Research and Development), End User (Biotechnology and Pharmaceutical Companies, Contract Research Organization, Academic and Research Institutions), and Geography - Insights, Size, Sha…

SomaLogic Blogs

Quality of Life or Quantity of Life? With proteomics maybe I can have both.

I'm like my dad in many ways — same nose, same horrible eyesight, same sense of humor. But when it comes to healthy lifespan, I’d really like to be more like my mom. The post Quality of Life or Quantity of Life? With proteomics maybe I can have both. appeared first on SomaLogic.

Patrick Terry announced as first Chief Commercial Officer of SomaLogic

SomaLogic announced today that Patrick Terry has joined the company as its first Chief Commercial Officer (CCO). A serial entrepreneur, biomedical science enthusiast and patient advocate, Terry is uniquely qualified to lead the commercialization of SomaLogic’s growing portfolio of protein-based prec…

SomaLogic launches its first SomaSignal™ tests in select medical practices

SomaLogic today launched its first seven SomaSignal™ tests, which are delivered simultaneously to provide actionable health information across a diverse set of human diseases and conditions. Each SomaSignal™ test is built on SomaLogic’s proprietary SomaScan® Platform, which measures thousands of hum…

The Question That DNA Cannot Answer

“Who are you?” This question, asked by the caterpillar in Alice in Wonderland, befuddled Alice. How would you answer this simply complicated question? The post The Question That DNA Cannot Answer appeared first on SomaLogic.

And the Winner is…

Wouldn’t it be great if everyone with diabetes could earn a lifetime achievement award for disease management? Given the skyrocketing costs of diabetes care in the U.S., this sounds like a win-win scenario. And maybe proteomics can make it happen. The post And the Winner is… appeared first on SomaLo…

SomaLogic’s clinical laboratory re-accredited by the College of American Pathologists

SomaLogic announced today that its United States clinical laboratory (CLIA laboratory) has been re-accredited by the College of American Pathologists (CAP). The successful renewal of CAP accreditation is based on the results of a recent on-site inspection designed to ensure the highest laboratory st…
Show more

SomaLogic Frequently Asked Questions

  • When was SomaLogic founded?

    SomaLogic was founded in 2000.

  • Who are SomaLogic key executives?

    SomaLogic's key executives are Larry Gold, Scott Kothlow and Stephen A. Williams.

  • How many employees does SomaLogic have?

    SomaLogic has 206 employees.

  • Who are SomaLogic competitors?

    Competitors of SomaLogic include Athelas, DAXOR and SurModics.

  • Where is SomaLogic headquarters?

    SomaLogic headquarters is located at 2945 Wilderness Pl, Boulder.

  • Where are SomaLogic offices?

    SomaLogic has an office in Boulder.

  • How many offices does SomaLogic have?

    SomaLogic has 1 office.